SCHEMBL8418003

SCHEMBL8418003

COc1ccc(N2CCN(CCCCn3c(C)nc(Cl)c3Cl)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.56
DRD2 P14416 7/20 0.53
HTR1A P08908 5/20 0.50
HTR2A P28223 5/20 0.50
HTR7 P34969 4/20 0.50
ADRA1A P35348 2/20 0.50
DRD4 P21917 2/20 0.48
HTR6 P50406 2/20 0.48
SOD1 P00441 1/20 0.47
KCNH2 Q12809 2/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1B P35368 1/20 0.46
DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416503 0.85 HTR1A (0.61) DRD2HTR1AHTR2AHTR7KCNH2
SCHEMBL8416455 0.81 HTR1A (0.62) HSD17B10DRD2HTR1AHTR2AHTR7
SCHEMBL8416472 0.78 KDM4E (0.61) DRD2HTR1AHTR2AHTR7ADRA1A
SCHEMBL8418004 0.76 HTR1A (0.48) DRD2HTR1AHTR2AHTR7DRD4
SCHEMBL10994325 0.76 HSD17B10 (0.73) HSD17B10DRD2HTR1AHTR2AHTR7
SCHEMBL16303868 0.76 DRD2 (0.79) HSD17B10DRD2HTR1AHTR2AHTR7
SCHEMBL8416539 0.75 HTR2A (0.55) DRD2HTR1AHTR2AHTR7ADRA1A
SCHEMBL8416352 0.75 SIGMAR1 (0.57) DRD2HTR1AHTR7ADRA1ADRD3
SCHEMBL3186225 0.74 HSD17B10 (0.91) HSD17B10DRD2HTR1AHTR2AHTR7
SCHEMBL18937451 0.74 DRD2 (0.82) HSD17B10DRD2HTR1AHTR2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 EP claimed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed